FDA approves first nasal spray to curb anaphylaxis, an alternative to injections
Folks nervous about administering a rescue shot for anaphylaxis finally have a new alternative in a nasal spray.
Aug 10, 2024
0
1
Folks nervous about administering a rescue shot for anaphylaxis finally have a new alternative in a nasal spray.
Aug 10, 2024
0
1
A multi-institutional team of biochemical engineers has developed an exosome-based delivery system that can carry beneficial proteins into cells to allow new kinds of medical treatments. Their paper is published in the journal ...
A team of researchers, led by the University of Houston, has discovered two new ways of preventing and treating respiratory viruses. In back-to-back papers in Nature Communications, the team—from the lab of Navin Varadarajan, ...
Aug 6, 2024
0
260
You've had a cold or the flu and your symptoms have begun to subside. Your nose has stopped dripping, your cough is clearing and your head and muscles no longer ache.
Aug 6, 2024
0
0
The nose is a major gateway to our bodies—for the air we breathe, the aromas we smell and the microbes that make us sick. On its way in, the air passes through nasal conchae, or turbinates—the long, narrow, curled shelves ...
Jul 31, 2024
0
39
If it seems like you suddenly know a lot of people with COVID-19 this summer, it's not just you.
Jul 29, 2024
0
0
Scientists in America have developed a nasal spray that can remove proteins in the brain associated with Alzheimer's disease—at least, in mice.
Jul 26, 2024
0
31
Scientists at ADA Forsyth Institute (AFI) have identified a critical factor that may contribute to the spread of hospital-acquired infections (HAIs), shedding light on why these infections are so difficult to combat. Their ...
Jul 22, 2024
0
0
A multi-institutional team of neuroscientists has developed a nasal therapy that cleared the brains of Alzheimer's mouse models of toxic tau proteins. In their study, published in the journal Science Translational Medicine, ...
The European Union has approved Sanofi and Regeneron's blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (COPD), the French pharmaceutical giant said on Wednesday.
Jul 3, 2024
0
0